/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Carlos Gil Ferreira

BioClinica (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

375

Papers

10.5K

Citations

42

h-index

118

i10-index

Carlos Gil Ferreira is an academic researcher from BioClinica (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Cancer Genomics and Diagnostics. The author has an h-index of 42, co-authored 319 publications.

ORCID: 0000-0002-7228-7018

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Genomics and Diagnostics RNA modifications and cancer Head and Neck Cancer Studies

Papers by this author

works

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

2019 · The Lancet · 3,270 citations

https://doi.org/10.1016/s0140-6736(18)32409-7

Tony Mok Yi‐Long Wu Iveta Kudaba Dariusz M. Kowalski

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

2020 · Journal of Thoracic Oncology · 429 citations

https://doi.org/10.1016/j.jtho.2020.01.005

William D. Travis Sanja Đačić Ignacio I. Wistuba Lynette M. Sholl

Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil

2014 · Infectious Agents and Cancer · 18 citations

https://doi.org/10.1186/1750-9378-9-25

Bruna Pedroso Tamegão-Lopes Edivaldo Costa Sousa-Júnior Fábio Passetti Carlos Gil Ferreira

TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells

2006 · BMC Cancer · 15 citations

https://doi.org/10.1186/1471-2407-6-166

Agnieszka Chęcińska Giuseppe Giaccone Bas S.J. Hoogeland Carlos Gil Ferreira

Increasing access to next-generation sequencing in oncology for Brazil

2019 · The Lancet Oncology · 13 citations

https://doi.org/10.1016/s1470-2045(18)30822-2

Marcos Santos Renata A. Coudry Carlos Gil Ferreira Stephen Stefani

Recurrent <i>WWTR1</i><scp>S89W</scp> mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix

2022 · The Journal of Pathology · 9 citations

https://doi.org/10.1002/path.5910

Sarah H. Kim Thais Basili Higinio Dopeso Arnaud Da Cruz Paula

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Cancer Genomics and Diagnostics

RNA modifications and cancer

Head and Neck Cancer Studies

Chat about Author

Papers

Chat

Click to start Chat